Related Experiment Video
Updated: Jan 26, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Targeting the Thioredoxin System as a Strategy for Cancer Therapy
Mianli Bian1, Rong Fan1, Sai Zhao1,2
1Institute of Chinese Medicine, School of Pharmacy , Nanjing University of Chinese Medicine , Nanjing 210023 , P. R. China.
Abstract:
Thioredoxin reductase (TrxR) participates in the regulation of redox reactions in organisms. It works mainly via its substrate molecule, thioredoxin, to maintain the redox balance and regulate signal transduction, which controls cell proliferation, differentiation, death, and other important physiological processes. In recent years, increasing evidence has shown that the overactivation of TrxR is related to the development of tumors. The exploration of TrxR-targeted antitumor drugs has attracted wide attention and is expected to provide new therapies for cancer treatment. In this perspective, we highlight the specific relationship between TrxR and apoptotic signaling pathways. The cytoplasm and mitochondria both contain TrxR, resulting in the activation of apoptosis. TrxR activity influences reactive oxygen species (ROS) and further regulates the inflammatory signaling pathway. In addition, we discuss representative TrxR inhibitors with anticancer activity and analyze the challenges in developing TrxR inhibitors as anticancer drugs.
Insights
Thioredoxin reductase (TrxR) regulates redox balance and cell signaling. Overactivated TrxR is linked to cancer, making TrxR inhibitors promising for new antitumor therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Thioredoxin reductase (TrxR) is crucial for redox homeostasis and cellular signaling.
- Dysregulation of TrxR is implicated in tumor development and progression.
- TrxR influences critical physiological processes including cell proliferation and apoptosis.
Purpose of the Study:
- To explore the relationship between TrxR and apoptotic signaling pathways.
- To review TrxR inhibitors with demonstrated anticancer activity.
- To analyze challenges in developing TrxR inhibitors for cancer treatment.
Main Methods:
- Literature review focusing on TrxR's role in apoptosis and cancer.
- Analysis of TrxR's involvement in reactive oxygen species (ROS) and inflammatory pathways.
- Discussion of existing TrxR inhibitors and their therapeutic potential.
Main Results:
- TrxR in cytoplasm and mitochondria activates apoptosis.
- TrxR activity modulates ROS levels, impacting inflammatory signaling.
- Several TrxR inhibitors exhibit anticancer effects in preclinical studies.
Conclusions:
- TrxR is a key regulator of apoptosis and a potential target for cancer therapy.
- Targeting TrxR offers a promising avenue for novel antitumor drug development.
- Overcoming challenges in TrxR inhibitor development is essential for clinical translation.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Gene Therapy
Group Therapy
Persuasion Strategies
Coping Strategies: Problem Focused
For example, consider a student who struggles to understand their...

